Millennium Management’s Better Therapeutics, Inc. Common Stock BTTX Stock Holding History

Millennium Management’s Portfolio BTTX Stock Details BTTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-128,749	Closed	-$25.1K	–	6818
2023 Q4	$25.1K	Buy	128,749 +91,876	+249%	+$20K	﹤0.01%	5598
2023 Q3	$14.2K	Buy	+36,873	New	+$24.9K	﹤0.01%	5710
2023 Q2	–	Sell	-26,556	Closed	-$19K	–	6900
2023 Q1	$19K	Buy	26,556 +14,932	+128%	+$17.5K	﹤0.01%	5881
2022 Q4	$13K	Sell	11,624 -2,632	-18%	-$3.88K	﹤0.01%	6148
2022 Q3	$25K	Buy	+14,256	New	+$26K	﹤0.01%	6408
2022 Q1	–	Sell	-68,310	Closed	-$318K	–	7718
2021 Q4	$318K	Sell	68,310 -22,221	-25%	-$182K	﹤0.01%	5478
2021 Q3	$903K	Buy	90,531 +34,536	+62%	+$344K	﹤0.01%	4801
2021 Q2	$555K	Buy	+55,995	New	+$556K	﹤0.01%	5216

Other funds holding BTTX

CIAS

Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

APC

Aspire Private Capital Cornelius, North Carolina $484M AUM 17.28% 1-Year Est. Return

Millennium Management's BTTX Position: Q1 2024 in Review

Millennium Management sold out of Better Therapeutics, Inc. Common Stock (BTTX) in Q1 2024, closing a stake of 128,749 shares — an estimated $25.1K sold.

Millennium Management first reported a position in BTTX in Q2 2021 and held it in 8 quarters. The position peaked at $903K in Q3 2021. 3 funds tracked by Wall St. Rank hold BTTX as of Q1 2024.

Millennium Management reported no remaining Better Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Millennium Management sold 128,749 Better Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $25.1K.
Millennium Management first reported a position in Better Therapeutics, Inc. Common Stock in Q2 2021 and held it in 8 quarters.
Millennium Management's Better Therapeutics, Inc. Common Stock position peaked at $903K in Q3 2021.
3 funds tracked by Wall St. Rank held Better Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.